Assembly Bill 679
The treatment of biological products for various purposes under the pharmacy practice law
Stopped before the full Assembly voted
The recommended passing it, but the full Assembly never voted on it. To try again, a lawmaker would have to start a new bill.
-
Introduced, passed
Nov 29, 2017
-
Committee, passed
Approved
-
Assembly vote, stopped here
Stopped here. The full Assembly never voted on it.
-
Senate vote, not reached
-
Governor, not reached
-
Law, not reached
Latest entry in the official record, Mar 28, 2018: “Failed to pass pursuant to ”
Following saves it on this device. New actions show on your Following page. You can also get updates in a feed reader.
Terms on this page
Committee
A small group of lawmakers that looks at a bill first. Most bills never leave committee.
Senate Joint Resolution 1
The session's calendar. Any bill not passed by its last voting day dies.
Official term: Failed to pass pursuant to SJR 1. More in the glossary
Legislative Reference Bureau
The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.
Official term: LRB analysis. More in the glossary
Author
A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.
Official term: Author, coauthor. More in the glossary
Signed on in support
Lawmakers who back a bill without being one of its authors, often from the other chamber.
Official term: Cosponsor. More in the glossary
Roll call
A vote where each lawmaker's yes or no is recorded by name.
Official term: Roll call vote. More in the glossary
What it would have done
Summary by the , the Legislature's nonpartisan drafting office. It's their wording, not ours.
This bill makes a number of changes to the pharmacy practice laws regarding the prescribing and dispensing of biological products, including changes to address the dispensing of interchangeable biological products.
Current state law contains a number of provisions that address the dispensing of drug product equivalents in lieu of the specific drug product described.
Read the full summary Show less
Specifically, current law allows a pharmacist to dispense the “drug product equivalent” of a drug prescribed if the drug product equivalent is lower in price to the consumer than the drug product prescribed, unless the prescribing practitioner specifically indicates on the prescription order that no substitution of the drug product prescribed may be made. Current law defines “drug product equivalent” as a drug product that the federal Food and Drug Administration, which regulates drugs pursuant to the Federal Food, Drug, and Cosmetic Act, has determined is therapeutically equivalent to the drug product prescribed. Current law also provides that if a pharmacist, pursuant to a prescription order that specifies a drug product by its brand name, dispenses the drug product equivalent of the drug product specified in the prescription order, the label required for the drug may include both the generic name of the drug product equivalent and the brand name specified in the prescription order, unless the prescribing practitioner requests that the brand name be omitted from the label.
This bill creates provisions similar to those described above that apply with respect to biological products, which are regulated somewhat differently from other drugs by the FDA under the federal Public Health Service Act. Specifically, the bill allows a pharmacist to dispense an interchangeable biological product in lieu of the biological product prescribed if the interchangeable biological product is lower in price to the consumer than the biological product prescribed, unless the prescribing practitioner specifically indicates on the prescription order that no substitution of the biological product prescribed may be made. The bill defines “interchangeable biological product” as a biological product that the FDA has determined is therapeutically equivalent to the biological product prescribed or that the FDA has licensed and determined meets standards for interchangeability pursuant to provisions in federal law. The bill further establishes requirements for pharmacists who dispense biological products to make an entry into an electronic records system or to otherwise communicate to the prescribing practitioner regarding the biological product dispensed, subject to certain exceptions. The bill provides that if a pharmacist, pursuant to a prescription order that specifies a biological product by its brand name, dispenses the interchangeable biological product of the biological product specified in the prescription order, the label required for the drug may include both the proper name of the interchangeable biological product and the brand name specified in the prescription order.
Current law also contains provisions regarding the labeling of prescription drugs, including requirements that certain information be contained on the commercial container of a prescription drug. The bill creates a similar provision that applies only to biological products, which includes a requirement that certain information to be contained on the commercial container of the biological product, including the brand name, if any, of the biological product, and the proper name of the biological product.
The provisions newly created in the bill apply only to biological products. The bill modifies the provisions under current law that apply to drugs generally so that they apply only to drugs that are not biological products.
Who's behind it
25 lawmakers are its . 14 are Republicans and 11 are Democrats.
9 more lawmakers .
See all 34 names Hide the names
Authors (25)
- Jimmy Anderson · Democrat, Assembly
- Terese Berceau · Democrat, Assembly
- Dave Considine · Democrat, Assembly
- David Crowley · Democrat, Assembly
- James Edming · Republican, Assembly
- Mary Felzkowski · Republican, Senate
- Jason Fields · Democrat, Assembly
- Cody Horlacher · Republican, Assembly
- André Jacque · Republican, Senate
- Debra Kolste · Democrat, Assembly
- Dale Kooyenga · Republican, Senate
- Jesse Kremer · Republican, Assembly
- Scott Krug · Republican, Assembly
- Mike Kuglitsch · Republican, Assembly
- Tod Ohnstad · Democrat, Assembly
- Rob Brooks · Republican, Assembly
- Mike Rohrkaste · Republican, Assembly
- Melissa Sargent · Democrat, Assembly
- Christine Sinicki · Democrat, Assembly
- Ken Skowronski · Republican, Assembly
- John Spiros · Republican, Assembly
- Mark Spreitzer · Democrat, Senate
- Lisa Subeck · Democrat, Assembly
- Jeremy Thiesfeldt · Republican, Assembly
- Ron Tusler · Republican, Assembly
Signed on in support (9)
- Barca and Shankland
- Kathleen Bernier · Republican, Senate
- Janet Bewley · Democrat, Senate
- Tim Carpenter · Democrat, Senate
- David Craig · Republican, Senate
- Howard Marklein · Republican, Senate
- Luther S. Olsen · Republican, Senate
- Kathleen Vinehout · Democrat, Senate
- Leah Vukmir · Republican, Senate
How lawmakers voted
There was one vote on this bill.
Assembly Committee on Health vote to recommend it
Passed, 11 to 0 · Mar 22, 2018
No member-by-member record exists for this vote. Committee votes and some older sessions record totals only.
Official motion: “Report passage recommended by Committee on Health, Ayes 11, Noes 0”. Official record · This vote on its own page
What happened
-
Mar 28, 2018
The session ended, and the bill died with it.
-
Mar 22, 2018
Sent to the Assembly Committee on Rules.
-
Mar 22, 2018
The committee voted to recommend passing it, 11 to 0.
-
Feb 20, 2018
2 more representatives signed on in support.
-
Dec 13, 2017
The committee held a public hearing.
-
Dec 7, 2017
1 more representative signed on in support.
-
Nov 29, 2017
Sent to the Assembly Committee on Health.
-
Nov 29, 2017
Introduced in the Assembly.
See the official record, word for word Hide the official record
- Nov 29, 2017 · Assembly
Introduced by Representatives Rohrkaste, Spiros, Kolste, Anderson, Berceau, R. Brooks, Considine, Crowley, Felzkowski, Fields, Horlacher, Jacque, Kooyenga, Kremer, Krug, Kuglitsch, Ohnstad, Sargent, Sinicki, Skowronski, Spreitzer, Thiesfeldt, Tusler, Subeck and Edming; cosponsored by Senators Vukmir, Carpenter, Craig, Olsen, Vinehout, Bewley and Marklein
- Nov 29, 2017 · Assembly
Read first time and referred to Committee on Health
- Dec 7, 2017 · Assembly
Representative Bernier added as a coauthor
- Dec 13, 2017 · Assembly
Public hearing held
- Feb 1, 2018 · Assembly
Executive action taken
- Feb 20, 2018 · Assembly
- Mar 22, 2018 · Assembly
Report passage recommended by Committee on Health, Ayes 11, Noes 0
- Mar 22, 2018 · Assembly
Referred to committee on Rules
- Mar 28, 2018 · Assembly
Failed to pass pursuant to Senate Joint Resolution 1
Terms on this page
Committee
A small group of lawmakers that looks at a bill first. Most bills never leave committee.
Senate Joint Resolution 1
The session's calendar. Any bill not passed by its last voting day dies.
Official term: Failed to pass pursuant to SJR 1. More in the glossary
Legislative Reference Bureau
The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.
Official term: LRB analysis. More in the glossary
Author
A lawmaker who formally puts a bill forward. The text itself is drafted by the Legislative Reference Bureau.
Official term: Author, coauthor. More in the glossary
Signed on in support
Lawmakers who back a bill without being one of its authors, often from the other chamber.
Official term: Cosponsor. More in the glossary
Roll call
A vote where each lawmaker's yes or no is recorded by name.
Official term: Roll call vote. More in the glossary
From the Wisconsin Legislature's official record, checked Sep 15, 2026. See the source
Committee
A small group of lawmakers that looks at a bill first. Most bills never leave committee.
Senate Joint Resolution 1
The session's calendar. Any bill not passed by its last voting day dies.
Official term: Failed to pass pursuant to SJR 1
Legislative Reference Bureau
The Legislature's nonpartisan office that drafts bills and writes the summary at the top of each one.
Official term: LRB analysis
Signed on in support
Lawmakers who back a bill without being one of its authors, often from the other chamber.
Official term: Cosponsor
Roll call
A vote where each lawmaker's yes or no is recorded by name.
Official term: Roll call vote